Search CAHR Abstracts

CLINICAL SCIENCES / SCIENCES CLINIQUES
ORAL PRESENTATIONS / PRÉSENTATIONS ORALES

THE SPECTRUM OF HIV: ACUTE, OPPORTUNISTIC, AND DUAL INFECTIONS AND MORTALITY

[156] FOLLOW-UP OF PATIENTS WITH ACUTE/EARLY HIV INFECTION WITHIN A CONTROLLED CLINICAL TRIAL (CTN 124)
B Conway, P Côté, D Rouleau, R LeBlanc, M Ostrowski, J Singer, RP Sékaly, M Wainberg, JP Routy
University of British Columbia, Vancouver, British Columbia; University of Toronto, Toronto, Ontario; Clinique du Quartier Latin, Clinique Lori, McGill University and Université de Montréal, Montreal, Quebec

[157] CHANGING PATTERNS OF OPPORTUNISTIC ILLNESS AND MORTALITY IN THE CANADIAN WOMEN'S HIV COHORT
S Walmsley¹, C Hankins², A Rachlis¹, D Burdge³, K Pourreaux², J Shu² and the Canadian Women's HIV Study Group
¹Department of Epidemiology and Biostatistics, University of Toronto; ²McGill University, Oak Tree Clinic; ³University of British Columbia

[158] SCREENING FOR ANAL CANCER
IE Salit¹, J Tinmouth², A Lytwyn³, W Chapman⁴, J Mahony⁵, J Raboud⁶, M Sano^1
1Immunodeficiency Clinic, Toronto General Hospital; ²Division of Gastroenterology, St. Michael's Hospital; ³Departments of Pathology, Sunnybrook and Women's College Health Sciences Centre; ⁴University Health Network; ⁵Department of Pathology and Molecular Medicine, McMaster University; ⁶Public Health, University of Toronto

[159] THE EFFECT OF HAART ON CERVICAL DYSPLASIA IN HIV INFECTED WOMEN
D Money¹, C Hankins^2,3, A Rachlis⁴, F Coutlee⁵, W Wobeser⁶, K Pourreaux², J-O Shu², and the Canadian Women's HIV Study Group
¹Oak Tree Clinic, Children's and Women's Health Centre of British Columbia and the Department of Obstetrics and Gynecology, University of British Columbia; ²Direction de la santé publique de Montréal-Centre;³Department of Epidemiology and Biostatistics, McGill University and Institut de santé publique du Québec; ⁴Sunnybrook Health Science Centre; ⁵Centre hospitalier de l'Université de Montréal; ⁶Queen's University

[160] HEPATITIS C IS AN INDEPENDENT PREDICTOR OF MORTALITY AMONG A POPULATION-BASED COHORT OF ANTIRETROVIRAL NAÏVE INDIVIDUALS INITIATING TRIPLE-COMBINATION THERAPY
P Braitstein, V Montessori, JSG Montaner, B Yip, MT Schechter, MV O'Shaughnessy, PR Harrigan, RS Hogg
BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia

[161] THE IMPACT OF THE HEPATITIS C VIRUS (HCV) ON CD4 RESPONSE POST INITIATION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) AMONG A POPULATION-BASED HIV COHORT
P Braitstein, JJ Asselin, V Montessori, E Wood, B Yip, K Chan, KJP Craib, MV O'Shaughnessy, MT Schechter, JSG Montaner, RS Hogg
BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia

[162] EVALUATION OF HIV-HCV CO-INFECTED SUBJECTS RECEIVING HCV TREATMENT AT THE OTTAWA HOSPITAL VIRAL HEPATITIS CLINIC
CL Cooper, A LaRoche, M Kane, GE Garber
Division of Infectious Diseases, The Ottawa Hospital, University of Ottawa

[163] CAUSES OF MORTALITY IN HIV INFECTED PATIENTS DURING THE HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY (HAART) ERA: A ONE-CENTER EXPERIENCE
JS Delisle¹, M Klein², R Lalonde², MD Edwardes³, JP Routy^1,2
1Divison of Hematology, ²Immunodeficiency Service and ³Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre, McGill University, Montreal, Quebec